Peak Bio, Inc. financial data

Symbol
PKBO on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4900 Hopyard Road, Suite 100, Pleasanton, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Ignyte Acquisition Corp. (to 11/2/2022)
Latest financial report
10-Q - Q2 2024 - Aug 23, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.63 % -49.7%
Debt-to-equity -109 % +8.12%
Return On Equity 23.5 % -86.9%
Return On Assets -254 % -110%
Operating Margin -1.91K % +46.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.1M shares +5.58%
Common Stock, Shares, Outstanding 23.1M shares +10.8%
Entity Public Float 17M USD -70%
Common Stock, Value, Issued 2.31K USD +10.8%
Weighted Average Number of Shares Outstanding, Basic 23.1M shares +14.2%
Weighted Average Number of Shares Outstanding, Diluted 23.1M shares +14.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 354K USD -24.3%
Research and Development Expense 722K USD -70.3%
General and Administrative Expense 6.4M USD -43.3%
Operating Income (Loss) -6.77M USD +59.6%
Nonoperating Income (Expense) 2.15M USD +79%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.8M USD +2.56%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.63M USD +78.1%
Earnings Per Share, Basic -0.18 USD/shares +83.6%
Earnings Per Share, Diluted -0.18 USD/shares +83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 236K USD +9.99%
Assets, Current 1.33M USD -12%
Property, Plant and Equipment, Net 31.8K USD -85.5%
Operating Lease, Right-of-Use Asset 0 USD -100%
Goodwill 0 USD
Other Assets, Noncurrent 11.1K USD +642%
Assets 1.43M USD -20.1%
Accounts Payable, Current 5.47M USD +6.7%
Accrued Liabilities, Current 4.4M USD +69.1%
Liabilities, Current 24M USD +33.4%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 24M USD +13.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 142K USD +27.3%
Retained Earnings (Accumulated Deficit) -42.7M USD -12.2%
Stockholders' Equity Attributable to Parent -22.6M USD -16.9%
Liabilities and Equity 1.43M USD -20.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.42M USD +1.56%
Net Cash Provided by (Used in) Financing Activities 1.11M USD -3.17%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 23.1M shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 296K USD +7.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50.9K USD
Deferred Tax Assets, Valuation Allowance 16M USD -44.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 16.1M USD -46.4%
Operating Lease, Liability 4.35M USD
Depreciation 31.8K USD -23.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.6M USD +78.2%
Lessee, Operating Lease, Liability, to be Paid 5.07M USD
Property, Plant and Equipment, Gross 753K USD -11.2%
Operating Lease, Liability, Current 4.6M USD +8.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.19M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 723K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.26M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 422K USD
Operating Lease, Payments 177K USD -77.5%
Additional Paid in Capital 19.9M USD +7.12%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 16M USD -44.5%
Share-based Payment Arrangement, Expense 7.48K USD -98.7%
Interest Expense 2.44M USD +121%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%